Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, California; and Departments of Medicine and.
Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, California; and Departments of Medicine and
Am J Physiol Endocrinol Metab. 2015 Jul 1;309(1):E22-34. doi: 10.1152/ajpendo.00513.2014. Epub 2015 May 5.
Reduced capillary density is a feature of skeletal muscle (SkM) in type 2 diabetes (T2D), which is associated with multiple metabolic and functional abnormalities. SkM has been identified as a secretory tissue, releasing myokines that regulate multiple processes, including vascularization. We sought to determine how myokines secreted from T2D myotubes might influence SkM angiogenesis. Conditioned media (CM) were generated by myotubes from T2D and nondiabetic (ND) subjects. Primary human endothelial cells (HUVEC) and SkM explants were exposed to CM or recombinant myokines, and tube number or capillary outgrowth was determined as well as measurement of protein expression and phosphorylation. CM from ND myotubes stimulated tube formation of HUVEC to a greater extent than T2D myotubes (T2D-CM = 100%, ND-CM = 288 ± 90% after 48 h, P < 0.05). The effects of T2D myotube CM were mediated by IL-8, not IL-15 or GROα, and were due not to cell damage but rather through regulating tube production and maintenance (response to T2D-IL-8 = 100%, response to ND-IL-8 = 263 ± 46% after 48 h, P < 0.05). A similar effect was seen in SkM explants with exposure to IL-8. The dose-dependent effect of IL-8 on tube formation was also observable in the PI3K and FAK signaling pathways and mediated at least in part by PI3K, leading to regulation of Tie2 expression. These results suggest that elevated levels of IL-8 secreted from T2D myotubes create a muscle microenvironment that supports reduced capillarization in T2D. Impaired vascularization of SkM limits the availability of substrates, including glucose and contributes to the T2D phenotype.
毛细血管密度降低是 2 型糖尿病(T2D)骨骼肌的特征,与多种代谢和功能异常有关。骨骼肌已被确定为一种分泌组织,释放肌因子调节多种过程,包括血管生成。我们试图确定来自 T2D 肌管的肌因子如何影响骨骼肌血管生成。T2D 和非糖尿病(ND)受试者的肌管产生条件培养基(CM)。将原代人内皮细胞(HUVEC)和骨骼肌外植体暴露于 CM 或重组肌因子中,并确定管数或毛细血管生长情况,以及测量蛋白表达和磷酸化。与 T2D 肌管相比,ND 肌管的 CM 更能刺激 HUVEC 管形成(T2D-CM = 100%,48 h 后 ND-CM = 288 ± 90%,P < 0.05)。T2D 肌管 CM 的作用是通过 IL-8 介导的,而不是通过 IL-15 或 GROα 介导的,并且不是由于细胞损伤,而是通过调节管的产生和维持(对 T2D-IL-8 的反应 = 100%,对 ND-IL-8 的反应 = 263 ± 46%,48 h 后,P < 0.05)。在暴露于 IL-8 的骨骼肌外植体中也观察到了类似的作用。IL-8 对管形成的剂量依赖性作用也可观察到在 PI3K 和 FAK 信号通路中,并至少部分通过 PI3K 介导,导致 Tie2 表达的调节。这些结果表明,来自 T2D 肌管的高水平 IL-8 分泌产生了一种支持 T2D 中毛细血管减少的肌肉微环境。SkM 血管化受损限制了包括葡萄糖在内的底物的可用性,并导致 T2D 表型。